Nutritional support in hepatic encephalopathy.
Hepatic encephalopathy (HE) is a syndrome of global cerebral dysfunction resulting from underlying liver disease or portal-systemic shunting. HE can present as one of four syndromes, depending on the rapidity of onset of hepatic failure and the presence or absence of preexisting liver disease. The precise pathogenesis is unknown but likely involves impaired hepatic detoxification of ammonia as well as alterations in brain transport and metabolism of amino acids and amines. The etiology of malnutrition in hepatic failure is multifactorial. Nutritional deficits may be clinically manifest as marasmus or kwashiorkor, or both. Nutritional support in HE is directed toward reducing morbidity related to underlying malnutrition and concurrent disease. However, reaching nutritional goals is often complicated by protein and carbohydrate intolerance. The use of protein restriction in HE is controversial. Modified formulas that are supplemented in branched chain amino acids may be of value in patients who exhibit protein intolerance with standard feeding solutions or in patients who present with advanced degrees of encephalopathy.
Mizock
B A
BA
Division of Critical Care Medicine, Cook County Hospital, Chicago, Illinois, USA.
D000596:Amino Acids / Q000378:metabolism; D000641:Ammonia / Q000378:metabolism; D050260:Carbohydrate Metabolism; D004044:Dietary Proteins / Q000008:administration & dosage; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D050356:Lipid Metabolism; D017093:Liver Failure / Q000150:complications / Q000378:metabolism / Q000628:therapy; D009748:Nutrition Disorders / Q000150:complications / Q000628:therapy; D018529:Nutritional Support; D011506:Proteins / Q000378:metabolism
D000596:Amino Acids; D004044:Dietary Proteins; D011506:Proteins; D000641:Ammonia